Biostage, Inc. (BSTG)

OTCMKTS: BSTG · Delayed Price · USD
0.00 (0.00%)
Mar 16, 2023, 12:00 AM EDT - Market closed

Total Valuation

Biostage has a market cap or net worth of $68.70 million. The enterprise value is $65.82 million.

Market Cap 68.70M
Enterprise Value 65.82M

Important Dates

The next earnings date is Tuesday, March 28, 2023, after market close.

Estimated Earnings Date Mar 28, 2023
Ex-Dividend Date n/a

Share Statistics

Biostage has 11.64 million shares outstanding. The number of shares has increased by 15.99% in one year.

Shares Outstanding 11.64M
Shares Change (YoY) +15.99%
Shares Change (QoQ) +3.43%
Owned by Insiders (%) 50.96%
Owned by Institutions (%) n/a
Float 5.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 31.10
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.04.

Current Ratio 2.21
Quick Ratio n/a
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -47.80%.

Return on Equity (ROE) -47.80%
Return on Assets (ROA) -28.85%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.88M
Employee Count 6
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +36.47% in the last 52 weeks. The beta is -0.93, so Biostage's price volatility has been lower than the market average.

Beta (1Y) -0.93
52-Week Price Change +36.47%
50-Day Moving Average 6.02
200-Day Moving Average 5.90
Average Volume (30 Days) 1,380

Short Selling Information

The latest short interest is 121,658, so 1.04% of the outstanding shares have been sold short.

Short Interest 121,658
Short Previous Month 201,811
Short % of Shares Out 1.04%
Short % of Float 2.35%
Short Ratio (days to cover) 3.35

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.56M
Pretax Income -11.30M
Net Income -11.30M
EBITDA -11.26M
EBIT -11.30M
Earnings Per Share (EPS) -$1.09
Full Income Statement

Balance Sheet

The company has $2.97 million in cash and $88,000 in debt, giving a net cash position of $2.88 million or $0.25 per share.

Cash & Cash Equivalents 2.97M
Total Debt 88,000
Net Cash 2.88M
Net Cash Per Share $0.25
Equity / Book Value 2.21M
Book Value Per Share 0.19
Working Capital 1.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.37 million and capital expenditures -$8,000, giving a free cash flow of -$3.38 million.

Operating Cash Flow -3.37M
Capital Expenditures -8,000
Free Cash Flow -3.38M
FCF Per Share -$0.30
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Biostage does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -16.45%
FCF Yield -4.92%
Dividend Growth (YoY) n/a
Payout Ratio -1.34%
Buyback Yield -15.99%
Shareholder Yield -15.99%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Sell
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 22, 2017. It was a reverse split with a ratio of 1:20.

Last Split Date Dec 22, 2017
Split Type Reverse
Split Ratio 1:20